Featured Editorial

  1. ADC CDMO Selection For Small Biotech 8/31/2026

    Manufacturing is a critical factor in ADC success. Discover how to align CDMO capabilities with molecule complexity, mitigate risks, and navigate capacity limits.

  2. More Than Half The Drug We Make Never Reaches A Patient 8/31/2026

    More than half the drug made for clinical trials may never reach a patient. Here’s where supply planning goes wrong, and where AI can actually help.

  3. Lessons In Forecasting Discipline From A $40B Supply Chain 8/31/2026

    Forecasting errors rarely start with the algorithm. They start when protocol changes, enrollment and site data reach the supply plan too late to prevent waste and disruption.

  4. Clinical Supply When There's No Drug To Ship 8/28/2026

    When a clinical trial has no drug to ship, what becomes supply? Non-pharmacological trials still require sourcing, tracking, qualification, and control.

  5. Why Clinical Supply Problems Rarely Start In Clinical Supply 8/27/2026

    Clinical supply failures often start long before a stockout, when CMC, quality, regulatory, and clinical decisions create risks that supply teams inherit too late.

  6. The Last Mile Nobody Talks About: What Really Happens To Unused Clinical Trial Supplies 8/26/2026

    Unused clinical trial supplies present complex logistical and compliance challenges. Learn why returns, reconciliation, and forecasting matter after a study ends.

  7. AI In Clinical Supply: From Forecasting To Execution Decisions 8/25/2026

    AI could shift clinical supply from periodic forecasting to continuous decisions, linking live signals with execution while protecting quality and patient continuity now.

  8. Accountability Gaps Can Break Clinical Supply Contracts 8/24/2026

    Contract gaps can create clinical supply failures when responsibilities differ across agreements. See how aligning obligations can prevent costly disputes, delays, and risks.

  9. When Clinical Supply Becomes A Clinical Decision 8/21/2026

    When clinical supply reveals a constraint, someone must decide what it means for patients and data. Strong governance turns those signals into accountable action.

  10. How To Build Clinical Supply Into Drug Development From The Start 8/21/2026

    Clinical supply can do more than execute development decisions. Bringing it in early can expose product, process, packaging, and patient-access risks while they can still be changed.